Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
12.18
-0.18 (-1.46%)
At close: Aug 29, 2025, 4:00 PM
12.16
-0.02 (-0.17%)
After-hours: Aug 29, 2025, 7:59 PM EDT
Phathom Pharmaceuticals Market Cap
Phathom Pharmaceuticals has a market cap or net worth of $848.32 million as of August 29, 2025. Its market cap has increased by 16.97% in one year.
Market Cap
848.32M
Enterprise Value
1.27B
1-Year Change
16.97%
Ranking
Category
Stock Price
$12.18
Market Cap Chart
Since October 25, 2019, Phathom Pharmaceuticals's market cap has increased from $527.13M to $848.32M, an increase of 60.93%. That is a compound annual growth rate of 8.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 860.85M | 55.05% |
| Dec 31, 2024 | 555.22M | 6.22% |
| Dec 29, 2023 | 522.72M | 13.23% |
| Dec 30, 2022 | 461.63M | -22.48% |
| Dec 31, 2021 | 595.53M | -36.35% |
| Dec 31, 2020 | 935.68M | 22.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.11B |
| Johnson & Johnson | 422.54B |
| AbbVie | 367.30B |
| UnitedHealth Group | 273.78B |
| Novo Nordisk | 249.15B |
| AstraZeneca | 247.41B |
| Novartis AG | 245.07B |
| Abbott Laboratories | 228.64B |